Keyphrases
Randomized Placebo-controlled Trial
100%
Sitagliptin
100%
Total Pancreatectomy with Islet Autotransplantation
100%
Total Pancreatectomy
85%
Islet Autotransplant
85%
Insulin Independence
42%
β-cell Apoptosis
28%
Placebo Groups
28%
Insulin
14%
Placebo
14%
Inhibitor Therapy
14%
Dipeptidyl peptidase-4 (DPP-4)
14%
Chronic Pancreatitis
14%
Hemoglobin A1c (HbA1c)
14%
Metabolic Outcomes
14%
Adverse Events
14%
Intravenous Glucose
14%
Insulin Dose
14%
Glucose Tolerance Test
14%
Mixed Meal
14%
A1c Levels
14%
Glucagon-like
14%
Glucose-dependent Insulinotropic Polypeptide
14%
Metabolic Testing
14%
Medicine and Dentistry
Pancreatectomy
100%
Placebo-Controlled Study
100%
Autotransplantation
100%
Sitagliptin
100%
Autograft
85%
Placebo
42%
Beta Cell
28%
Programmed Cell Death
28%
Dipeptidyl Peptidase-4 Inhibitor
14%
Glucagon Like Peptide 1
14%
Adverse Event
14%
Hemoglobin A1c
14%
Glucose Tolerance
14%
Chronic Pancreatitis
14%
Gastric Inhibitory Polypeptide
14%